Leerink Partnrs Forecasts Revvity's Q1 Earnings (NYSE:RVTY)

Revvity Inc. (NYSE:RVTY - Free Report) - Analysts at Leerink Partnrs reduced their Q1 2026 earnings per share (EPS) estimates for shares of Revvity in a research report issued to clients and investors on Monday, June 23rd. Leerink Partnrs analyst P. Souda now anticipates that the company will earn $1.14 per share for the quarter, down from their prior forecast of $1.15. The consensus estimate for Revvity's current full-year earnings is $4.94 per share. Leerink Partnrs also issued estimates for Revvity's Q3 2026 earnings at $1.38 EPS and FY2027 earnings at $6.31 EPS.

Other equities analysts have also issued reports about the stock. Wall Street Zen lowered shares of Revvity from a "buy" rating to a "hold" rating in a research report on Saturday, May 24th. Barclays dropped their price objective on shares of Revvity from $140.00 to $110.00 and set an "overweight" rating on the stock in a research report on Thursday, April 10th. UBS Group raised shares of Revvity from a "neutral" rating to a "buy" rating and dropped their price objective for the company from $145.00 to $115.00 in a research report on Thursday, May 1st. Robert W. Baird dropped their price objective on shares of Revvity from $127.00 to $125.00 and set an "outperform" rating on the stock in a research report on Tuesday, April 29th. Finally, Wells Fargo & Company dropped their price objective on shares of Revvity from $130.00 to $102.00 and set an "equal weight" rating on the stock in a research report on Thursday, April 17th. Five analysts have rated the stock with a hold rating, ten have issued a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average target price of $123.64.

Revvity Stock Performance

Shares of RVTY traded down $1.01 during trading hours on Tuesday, hitting $97.78. The company had a trading volume of 1,331,016 shares, compared to its average volume of 971,406. The firm has a market cap of $11.53 billion, a price-to-earnings ratio of 41.61, a PEG ratio of 2.41 and a beta of 0.97. The business has a fifty day moving average of $93.36 and a 200-day moving average of $105.45. Revvity has a 12 month low of $87.70 and a 12 month high of $129.50. The company has a quick ratio of 2.99, a current ratio of 3.58 and a debt-to-equity ratio of 0.41.

Revvity (NYSE:RVTY - Get Free Report) last announced its quarterly earnings results on Monday, April 28th. The company reported $1.01 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.96 by $0.05. Revvity had a return on equity of 7.73% and a net margin of 10.35%. The business had revenue of $664.76 million during the quarter, compared to the consensus estimate of $662.30 million. During the same quarter last year, the firm posted $0.98 EPS. The company's quarterly revenue was up 2.3% on a year-over-year basis.

Revvity Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, August 8th. Shareholders of record on Friday, July 18th will be issued a $0.07 dividend. This represents a $0.28 annualized dividend and a yield of 0.29%. The ex-dividend date of this dividend is Friday, July 18th. Revvity's dividend payout ratio is currently 11.91%.

Hedge Funds Weigh In On Revvity

Several hedge funds have recently bought and sold shares of RVTY. Assetmark Inc. increased its holdings in Revvity by 3,700.0% in the 4th quarter. Assetmark Inc. now owns 266 shares of the company's stock valued at $30,000 after buying an additional 259 shares during the period. Optiver Holding B.V. bought a new position in Revvity in the 4th quarter valued at about $33,000. Quarry LP increased its holdings in Revvity by 45.7% in the 4th quarter. Quarry LP now owns 303 shares of the company's stock valued at $34,000 after buying an additional 95 shares during the period. Millstone Evans Group LLC bought a new position in Revvity in the 4th quarter valued at about $38,000. Finally, Vermillion Wealth Management Inc. bought a new position in Revvity in the 4th quarter valued at about $41,000. 86.65% of the stock is owned by institutional investors.

Revvity Company Profile

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.